查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386125

日本脑炎疫苗市场报告：2030 年趋势、预测与竞争分析

Japanese Encephalitis Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

日本脑炎疫苗的趋势与预测

预计2030年，全球日本脑炎疫苗市场将达到约3亿美元，2024年至2030年的年复合成长率为5.8%。该市场的主要驱动因素是日本脑炎患者数量的增加、口服药物需求的增加以及由于都市化而增加的日本脑炎暴露风险。全球日本脑炎疫苗市场的未来看起来充满希望，医院、零售和线上市场都有机会。

日本脑炎疫苗市场洞察

Lucintel 预测，由于减毒活病毒疫苗的有效性和在体内诱导强烈免疫反应的作用，减毒活疫苗将继续成为最大的细分市场。

在同一市场中，医院预计将在预测期内实现最高成长。

由于印度、中国和日本的日本脑炎风险增加，亚太地区仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球B型脑炎疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球B型脑炎疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按类型：全球日本脑炎疫苗市场
    • 失活
    • 重组
    • 减弱毒性
  • 按配销通路：全球日本脑炎疫苗市场
    • 医院
    • 零售
    • 线上的
  • 按应用划分：全球日本脑炎疫苗市场
    • 儿童用疫苗
    • 成人疫苗

第4章2018-2030年分地区市场趋势及预测分析

  • 全球B型脑炎疫苗市场区域分布
  • 北美乙型脑炎疫苗市场
  • 欧洲日本脑炎疫苗市场
  • 亚太日本脑炎疫苗市场
  • 其他地区B型脑炎疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球日本脑炎疫苗市场成长机会（按类型）
    • 全球日本脑炎疫苗市场成长机会（按配销通路）
    • 全球日本脑炎疫苗市场成长机会（按应用）
    • 全球日本脑炎疫苗市场成长机会（按地区）
  • 全球B型脑炎疫苗市场新趋势
  • 战略分析
    • 新产品开发
    • 全球B型脑炎疫苗市场产能扩张
    • 全球B型脑炎疫苗市场的合併、收购与合资
    • 认证和许可

第7章主要企业概况

  • Valneva
  • Sanofi
  • Bharat Biotech International
  • Chengdu Institute of Biological Products
  • Adimmune
简介目录

Japanese Encephalitis Vaccine Trends and Forecast

The future of the global japanese encephalitis vaccine market looks promising with opportunities in the hospital, retail, and online markets. The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing cases of japanese encephalitis, increasing demand for oral drugs, and irising risk of exposure to japanese encephalitis given to urbanization.

A more than 150-page report is developed to help in your business decisions.

Japanese Encephalitis Vaccine by Segment

The study includes a forecast for the global japanese encephalitis vaccine by type, distribution channel, application, and region.

Japanese Encephalitis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated
  • Recombinant
  • Live Attenuated

Japanese Encephalitis Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Retail
  • Online

Japanese Encephalitis Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pediatric Vaccines
  • Adult Vaccines

Japanese Encephalitis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Japanese Encephalitis Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies japanese encephalitis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the japanese encephalitis vaccine companies profiled in this report include-

  • Valneva
  • Sanofi
  • Bharat Biotech International
  • Chengdu Institute of Biological Products
  • Adimmune

Japanese Encephalitis Vaccine Market Insights

Lucintel forecasts that live attenuated will remain the largest segment due to its effectiveness and inducing a strong immune response to the body.

Within this market, hospital is expected to witness highest growth over the forecast period.

APAC will remain the largest regiondue to rising risk of japanese encephalitis in India, China, and Japan.

Features of the Global Japanese Encephalitis Vaccine Market

Market Size Estimates: Japanese encephalitis vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Japanese encephalitis vaccine market size by type, distribution channel, application, and region in terms of value ($B).

Regional Analysis: Japanese encephalitis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, applications, and regions for the japanese encephalitis vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the japanese encephalitis vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the japanese encephalitis vaccine market size?

Answer: The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030.

Q.2 What is the growth forecast for japanese encephalitis vaccine market?

Answer: The global japanese encephalitis vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the japanese encephalitis vaccine market?

Answer: The major drivers for this market are growing cases of japanese encephalitis, increasing demand for oral drugs and irising risk of exposure to japanese encephalitis given to urbanization.

Q4. What are the major segments for japanese encephalitis vaccine market?

Answer: The future of the japanese encephalitis vaccine market looks promising with opportunities in the hospital, retail, and online markets.

Q5. Who are the key japanese encephalitis vaccine market companies?

Answer: Some of the key japanese encephalitis vaccine companies are as follows:

  • Valneva
  • Sanofi
  • Bharat Biotech International
  • Chengdu Institute of Biological Products
  • Adimmune

Q6. Which japanese encephalitis vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that live attenuated will remain the largest segment due to its effectiveness and inducing a strong immune response to the body.

Q7. In japanese encephalitis vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC will remain the largest regiondue to rising risk of japanese encephalitis in India, China, and Japan.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the japanese encephalitis vaccine market by type (inactivated, recombinant, and live attenuated), distribution channel (hospitals, retail, and online), application (pediatric vaccines and adult vaccines), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Japanese Encephalitis Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Japanese Encephalitis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Japanese Encephalitis Vaccine Market by Type
    • 3.3.1: Inactivated
    • 3.3.2: Recombinant
    • 3.3.3: Live Attenuated
  • 3.4: Global Japanese Encephalitis Vaccine Market by Distribution Channel
    • 3.4.1: Hospitals
    • 3.4.2: Retail
    • 3.4.3: Online
  • 3.5: Global Japanese Encephalitis Vaccine Market by Application
    • 3.5.1: Pediatric Vaccines
    • 3.5.2: Adult Vaccines

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Japanese Encephalitis Vaccine Market by Region
  • 4.2: North American Japanese Encephalitis Vaccine Market
    • 4.2.2: North American Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
  • 4.3: European Japanese Encephalitis Vaccine Market
    • 4.3.1: European Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
    • 4.3.2: European Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
  • 4.4: APAC Japanese Encephalitis Vaccine Market
    • 4.4.1: APAC Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
    • 4.4.2: APAC Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
  • 4.5: ROW Japanese Encephalitis Vaccine Market
    • 4.5.1: ROW Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
    • 4.5.2: ROW Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Japanese Encephalitis Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Japanese Encephalitis Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Japanese Encephalitis Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Valneva
  • 7.2: Sanofi
  • 7.3: Bharat Biotech International
  • 7.4: Chengdu Institute of Biological Products
  • 7.5: Adimmune